Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-26FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2019-08-14FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) from GlaxoSmithKline LLC.
-
FDA approval · 2019-08-14FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for LAMICTAL (lamotrigine) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness [NA]
A completed clinical trial assessing a real-time mobile cognitive behavioral intervention for serious mental illness (schizophrenia and bipo…
-
CLINICAL_TRIALS research · 2019-08-06Clinical Trial Update: Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome [NA]
Clinical trial update related to anticonvulsants, mood stabilizers, and antipsychotics in relation to insulin resistance, with completed sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression [Phase 3]
Phase 3 clinical trial evaluating minocycline and celecoxib as adjunctive treatments for bipolar depression has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: High Deductible Health Plans and Bipolar Disorder
Clinical trial update on the impact of high deductible health plans on bipolar disorder; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder. [Phase 3]
Phase 3 long-term study of SM-13496 in patients with Bipolar I Disorder has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression [Phase 3]
A Phase 3 double-blind, placebo-controlled trial of divalproex sodium extended-release for bipolar I or II depression has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness) [NA]
Completed clinical trial studying PTSD services for veterans with severe mental illness; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Nitrous TRD Bipolar Depression [EARLY_Phase 1]
Early-phase trial update for nitrous oxide in treatment-resistant bipolar disorder and bipolar depression; study terminated with results pos…
-
FDA approval · 2019-07-01FDA Approved: HALOPERIDOL — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for haloperidol lactate (HALOPERIDOL LACTATE) as a generic injectable from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder [Phase 3]
Phase 3 clinical trial update on long-term safety and tolerability of cariprazine for Bipolar I Disorder.
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression [Phase 4]
Phase 4 comparative effectiveness trial comparing lamotrigine to fluoxetine in bipolar depression was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Ketamine for Suicidality in Bipolar Depression [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating ketamine for suicidality in bipolar depression; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Brain Mechanisms of Human Motivation
Completed clinical trial investigating brain mechanisms of human motivation in Major Depressive Disorder and Bipolar Disorder; results poste…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder [Phase 4]
Phase 4 clinical trial assessing the effect of oxcarbazepine on serum brain-derived neurotrophic factor (BDNF) in bipolar disorder has compl…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Implementing Health Plan-Level Care Management for Solo & Small Practices [NA]
Clinical trial update on care management implementation for solo and small practices in bipolar disorder and depression; study completed wit…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods
Clinical trial evaluating two self-assessment tools (KIOS-Bipolar and eMoods) for bipolar disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders [Phase 2]
Phase 2 trial evaluating pentosan polysulfate sodium and meclofenamic acid for psychotic disorders, completed with posted results.
-
FDA approval · 2019-03-19FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved Zydus Pharmaceuticals USA Inc.'s original application for lurasidone hydrochloride (generic lurasidone).
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy [Phase 4]
Phase 4 clinical trial comparing propofol target-controlled infusion anesthesia with bolus injection for electroconvulsive therapy in adults…
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study [Phase 2]
Phase 2 double-blind, placebo-controlled trial evaluating taurine as an anti-manic agent in bipolar disorder with mania.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial [NA]
This update reports on a pilot clustered randomized controlled trial evaluating the potential efficacy of the Chinese Health Improvement Pro…
-
FDA approval · 2019-02-21FDA Approved: ARIPIPRAZOLE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic version of aripiprazole.